Rxcurve
HCPCS J3372 · per 500 MG

Inj, vancomycin hcl (xellia)

This code is not in the latest file (4Q26). It was last listed in 2Q25.

Payment limit per 500 MG, by effective quarter, 1Q23 to 2Q25. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J3372

No NDCs mapped to this code in the 4Q26 crosswalk.

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
2Q25 $6.544 +$0.165 500 MG Inj, vancomycin hcl (xellia) v1, posted March 10, 2026
1Q25 $6.379 −$0.038 500 MG Inj, vancomycin hcl (xellia) v1, posted December 19, 2025
4Q24 $6.417 −$0.064 500 MG Inj, vancomycin hcl (xellia) v1, posted June 11, 2025
3Q24 $6.481 +$0.08 500 MG Inj, vancomycin hcl (xellia) v1, posted June 11, 2025
2Q24 $6.401 −$0.177 500 MG Inj, vancomycin hcl (xellia) v1, posted March 11, 2025
1Q24 $6.578 +$0.087 500 MG Inj, vancomycin hcl (xellia) v1, posted December 19, 2024
4Q23 $6.491 −$0.087 500 MG Inj, vancomycin hcl (xellia) v1, posted October 10, 2024
3Q23 $6.578 +$0.014 500 MG Inj, vancomycin hcl (xellia) v1, posted June 5, 2024
2Q23 $6.564 +$0.073 500 MG Inj, vancomycin hcl (xellia) v1, posted February 23, 2024
1Q23 $6.491 – 500 MG Inj, vancomycin hcl (xellia) v1, posted December 6, 2023

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files